Breast Cancer

Studies show inexpensive, generic drugs can help reduce breast cancer mortality in postmenopausal women.

Novel oral soluble film is indicated to prevent highly and moderately emetogenic chemotherapy-induced nausea and vomiting.

Amino acid abundant in meat and fish could open receptors in cancer cells.

Particles are surrounded by a protective coating to release drugs in the presence of a specific tumor enzyme.

Silver is a useful element to prevent bacterial growth.

Study finds less than half of cancer patients have a completed will.

Targeting protein that helps cancer cells survive chemotherapy shows promise.

Hormones that reduce side effects may stimulate growth of cells resistant to therapy.

Size and speed of tumor growth similar in dogs and humans.

Increasing immune cell infiltration into tumors induces the immune system to block tumor growth.

Duration of sleep and snoring may play a role in survival outcomes.

Early palliative care reduces costs more than traditional treatment standards.

Glioblastoma treatment with surgical resection may benefit patients with worst prognoses.

Undertreated side effects in treatment of some colon and stomach cancers need to be addressed.

Combination therapy with AKT inhibitors shows promise.

Test projects which agent will work best against particular tumors.

Treatment advances have caused significant progress in survivorship.

Top stories of the week on Specialty Pharmacy Times from May 18 to May 22.

New approach seeks to lessen resistance to cancer drugs while mitigating adverse events.

Black men more likely to be diagnosed with breast cancer at a younger age than white men.

Excess medical expenses, employment disability, and a drop in production at work common in cancer survivors.

Study warns that drug reviewers don't look at long term survival of patients.

Particles protected antigen from premature destruction and prompted the immune system to attack cancer cells.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses changes in store for the care of cancer patients over the next decade.

Mass spectrometry reveals all proteins that repair damaged cancer DNA.